Question

In 2016, the top-selling pharmaceutical drug in the world was AbbVie's Humira, which is used for the treatment of several common, chronic conditions. The majority of its profits are derived from treatment of the most common diseases, so why does AbbVie develop drugs for rare diseases instead of investing all of its resources toward drugs for common diseases? Use the marginal principle to briefly explain your answer.

    In 2016, the top-selling pharmaceutical drug in the world was AbbVie's Humira, which is used for the treatment of several common, chronic conditions. The majority of its profits are derived from treatment of the most common diseases, so why does AbbVie develop drugs for rare diseases instead of investing all of its resources toward drugs for common diseases? Use the marginal principle to briefly explain your answer.

Principles of Microeconomics

Stevenson,… 1st Edition

Chapter 1, Problem 5

Instant Answer

Step 1

If the marginal benefit of an action exceeds the marginal cost, then the action should be pursued. This principle can be applied to understand why a pharmaceutical company like AbbVie might choose to develop drugs for rare diseases even when the majority of its Show more…

Show all steps

Thanks for your feedback!

In 2016, the top-selling pharmaceutical drug in the world was AbbVie's Humira, which is used for the treatment of several common, chronic conditions. The majority of its profits are derived from treatment of the most common diseases, so why does AbbVie develop drugs for rare diseases instead of investing all of its resources toward drugs for common diseases? Use the marginal principle to briefly explain your answer.

Play audio

Feedback

Ace is your personal tutor. It breaks down any question with clear steps so you can learn.

Start Using Ace

Continue solving this problem

Create a free account to:

View full step-by-step solution
Ask follow-up questions with Ace AI
Save progress and study later

Please give Ace some feedback